Key Market Indicator:
One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities
US42328V1089
© Globe Newswire
18.11.2025
HSDT
LISTED
NASDAQ
Solana Company Reports Third Quarter 2025 Financial Results
News Preview
NEWTOWN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury (“DAT”) dedicated to acquiring and holding Solana tokens (“SOL”), today announced results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
HSDT
LISTED
NASDAQ
Solana Company to Release Third Quarter Operating Results on November 18, 2025
News Preview
NEWTOWN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced that the Company will release its third quarter operating results on Tuesday, Novembe...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
HSDT
LISTED
NASDAQ
CORRECTION – Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield
News Preview
NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Wednesday, October 29th by Solana Company (NASDAQ: HSDT), please note that in the first sentence of the third paragraph, the increase of the amount of "SOL" held should be roughly 0.1 million, not 1 million. The corrected release follows: ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
Advertisment
20.10.2025
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
29.10.2025
HSDT
LISTED
NASDAQ
Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield
News Preview
NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”) today announced its updated Solana (“SOL”) token and cash holdings as of Oct. 29 at 12:00 am ET, as well as its current staking performance....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
HSDT
LISTED
NASDAQ
Solana Company (NASDAQ: HSDT) Strengthens Treasury Strategy with Helius, Anchorage Digital and Twinstake Staking Services
News Preview
NEWTOWN, Pa., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT or the “Company”) announced that it has entered into agreements with Helius and Twinstake (each, a “Provider,” and collectively, the “Providers”), related to non-custodial staking services. The Company is also staking its SOL holdings directly from qualified custody at A...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
HSDT
LISTED
NASDAQ
Solana Company Executive Chairman’s Message: October 20th, 2025
News Preview
NEWTOWN, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Today, Solana Company (NASDAQ: HSDT) released the following letter from the Executive Chairman:...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2025
HSDT
LISTED
NASDAQ
Preeminent SOL Treasury Vehicle, Solana Company (NASDAQ:HSDT), Adds Coinbase, BitGo, and Anchorage Digital as Custodians
News Preview
NEWTOWN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Solana Company, (NASDAQ:HSDT or “the Company"), formerly Helius Medical Technologies, Inc., today announced it has entered into agreements with Coinbase, BitGo and Anchorage Digital to serve as custodians as it continues amassing SOL, the native asset of the Solana Network, as part of its digital as...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
HSDT
LISTED
NASDAQ
Preeminent SOL Treasury Company Helius (NASDAQ:HSDT) Announces Corporate Name Change to Solana Company and Letter of Intent with Solana Foundation
News Preview
HSDT Solana Company's Mission is to maximize SOL per share on one of the most commercially viable blockchains for consumer applications while delivering consistent on-chain yield for investors...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
HSDT
LISTED
NASDAQ
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
News Preview
Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device Designation Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device Designation...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
HSDT
LISTED
NASDAQ
Helius (NASDAQ:HSDT) Begins Purchases of SOL, the Native Asset of Solana Blockchain
News Preview
NEWTOWN, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (the "Company" or "HSDT"), today announced its first acquisition of Solana (“SOL”) tokens as part of its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana Blockchain. The Company now holds over 760...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.07.2025
HSDT
LISTED
NASDAQ
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
News Preview
NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive outcome from the PoNS (Portable Neuromodulation Stimulator) Stroke Registrational Program (SRP) supporting...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
12.06.2025
HSDT
LISTED
NASDAQ
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
News Preview
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis-...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device
News Preview
-Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS reimbursement-...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.06.2025
HSDT
LISTED
NASDAQ
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
News Preview
NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of its public offering of an aggregate of 2,768,600 shares of its Class A co...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.06.2025
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
News Preview
Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq’s Equity Rule requirement Company previously granted extension until June 30, 2025 to regain compliance with Nasdaq’s Equity Rule requirement...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.05.2025
HSDT
LISTED
NASDAQ
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting
News Preview
Shepherd Center’s Dr. Deborah Backus to Showcase Final Results of PoNSTEP Study, Providing New Insight into Maximizing Impact of Neuromodulation to Improve Gait in People with MS Shepherd Center’s Dr. Deborah Backus to Showcase Final Results of PoNSTEP Study, Providing New Insight into Maximizing Impact of Neuromodulation to Improve Gait in People...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2025
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
News Preview
NEWTOWN, Pa., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced today announced it has entered into agreements with certain holders of its existing warra...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2025
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
News Preview
--128 enrolled participants, as of December 31, 2024, exceeds initial target of 90 participants-- --150 maximum participant enrollment projected by end of January--...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.12.2024
HSDT
LISTED
NASDAQ
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System
News Preview
Initial order placed with Company’s distributor at contracted price and represents operational implementation through VA Federal Supply Schedule (FSS) Contract Initial order placed with Company’s distributor at contracted price and represents operational implementation through VA Federal Supply Schedule (FSS) Contract...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.11.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device
News Preview
Management to host business update call today at 9:00am ET Management to host business update call today at 9:00am ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece
News Preview
-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius -- -- National Reimbursement Payment Determination from CMS for its PoNS Controller Deferred to the Next Cycle --...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.08.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
News Preview
NEWTOWN, Pa., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that, effective August 14, 2024, its independent directors approved equity awards under Helius’ 2021 Inducement Plan, as a material inducement to three...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.08.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results
News Preview
Company to host call at 4:30pm today Company to host call at 4:30pm today...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.06.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
News Preview
-- Inclusion of the top neurorehabilitation centers REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions completes site participation enrollment for the U.S. registrational program in stroke -- -- In Canada, an additional study on the use of Portable Neuromodulation Stimulator (PoNS®) Therapy to treat stroke has sta...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.05.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
News Preview
-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to multiple sclerosis (MS) access to the only portable neurostimulation therapy with the potential to generate neuroplasticity -- NEWTOWN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.05.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
News Preview
Company to host call at 4:30pm today Company to host call at 4:30pm today...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.05.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024
News Preview
NEWTOWN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Company will release its first quarter 2024 financial results on Monday, May 13,...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2024
HSDT
LISTED
NASDAQ
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
News Preview
NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the pricing of a public offering of 804,999 shares of its Class A common stock (“Common S...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
